Results 51 to 60 of about 15,427 (288)
Indian Journal of Dermatology, 2019 Background: Vascular endothelial growth factor (VEGF) is significantly elevated in psoriatic patients and is associated with the severity of the psoriasis.
Wei Ding +6 more
doaj +1 more source
Circulating microRNA profile unveils mechanisms of action of acitretin for psoriasis vulgaris
Bioengineered, 2021 Psoriasis vulgaris is a common chronic and recurrent inflammatory skin disease. In clinical practice, acitretin is the first-line treatment drug for psoriasis vulgaris.
Lin Chen +6 more
semanticscholar +1 more source
Evaluation of acitretin side effects on Iraqi psoriatic patients
The Iraqi Journal of Veterinary Medicine, 2010 Acitretin is the major metabolite of etretinate , an aromatic retinoid that formerly was approved for Psoriasis by exhibiting vitamin A activity. Acitretin was wildly used to improve plaque psoriasis and also for postural psoriasis and erthrodemic ...
Ahmed H. Kadhim +3 more
doaj +1 more source
Chinese Medical Journal, 2015 Background: Few clinical trials have evaluated the efficacy and safety of Tripterygium wilfordii Hook F (TwHF) compared with acitretin in psoriasis. We aimed to compare the efficacy and safety of TwHF compared with acitretin in the treatment of moderate ...
Chao Wu +9 more
doaj +1 more source
Acitretin-Induced Necrotizing Sweet’s Syndrome in a Patient Having Psoriasis
Journal of Gandhara Medical and Dental Sciences, 2023 A 52-year-old male presented with multiple tender, plum-coloured facial plaques following the treatment with acitretin 50 mg/day for his psoriasis. The lesions subsided over 3 months. Acitretin was restarted at 20 mg/day as psoriasis flared.
Karolina Nemeth +3 more
doaj +1 more source
Acitretin in pediatric dermatoses
Indian Journal of Paediatric Dermatology, 2016 Acitretin, a synthetic retinoid and the active metabolite of etretinate has been increasingly used over the past two decades. It has proved effective in the treatment of many conditions associated with hyperkeratosis and dyskeratosis.
Manjyot Gautam +4 more
doaj +1 more source
Nuclear Receptors as Therapeutic Targets for Neurodegenerative Diseases: Lost in Translation [PDF]
, 2019 Neurodegenerative diseases are characterized by a progressive loss of neurons that leads to a broad range of disabilities, including severe cognitive decline and motor impairment, for which there are no effective therapies.
Codocedo, Juan F. +3 more
core +1 more source
Journal of Clinical Medicine, 2021 The study aimed to evaluate the effect of retinoid treatment on the morphological changes in the nail apparatus in patients with nail psoriasis. Material and methods: 41 patients aged 32 to 64 with nail psoriasis, without clinical signs of psoriatic ...
M. Krajewska-Włodarczyk +2 more
semanticscholar +1 more source
Dermatologic Therapy, 2021 Dear Editor, Midostaurin is a FMS-like tyrosine kinase 3 (FLT3) inhibitor and has been approved for the management of FTL3-mutant acute myeloid leukemia (AML). We report bullous Sweet syndrome in a patient with AML related to midostaurin treatment with a
S. Chiewchanvit +5 more
semanticscholar +1 more source
Acta Pharmaceutica Sinica B, 2014 Acitretin is a photosensitive oral retinoid with very limited data available on its degradation. The official HPLC method for acitretin determination was insufficient to resolve the degradation products generated during stability studies.
Pawan K. Porwal, Neeraj Upmanyu
doaj +1 more source